Anthera Pharmaceuticals Inc (ANTH)
0.00
USD |
OTCM |
Mar 27, 16:00
Anthera Pharmaceuticals Cash from Financing (TTM): 19.03M for March 31, 2018
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2018 | 19.03M |
December 31, 2017 | 18.25M |
September 30, 2017 | 16.19M |
June 30, 2017 | 34.08M |
March 31, 2017 | 36.08M |
December 31, 2016 | 23.58M |
September 30, 2016 | 23.90M |
June 30, 2016 | 33.89M |
March 31, 2016 | 31.30M |
December 31, 2015 | 75.30M |
September 30, 2015 | 67.61M |
June 30, 2015 | 37.91M |
March 31, 2015 | 37.92M |
December 31, 2014 | -7.706M |
September 30, 2014 | -1.076M |
June 30, 2014 | -0.346M |
March 31, 2014 | 2.835M |
Date | Value |
---|---|
December 31, 2013 | 43.12M |
September 30, 2013 | 41.28M |
June 30, 2013 | 74.61M |
March 31, 2013 | 71.41M |
December 31, 2012 | 31.26M |
September 30, 2012 | 33.59M |
June 30, 2012 | -0.28M |
March 31, 2012 | 53.81M |
December 31, 2011 | 78.43M |
September 30, 2011 | 78.16M |
June 30, 2011 | 107.94M |
March 31, 2011 | 55.91M |
December 31, 2010 | 87.53M |
September 30, 2010 | 90.75M |
June 30, 2010 | 71.48M |
March 31, 2010 | 69.41M |
December 31, 2009 | 13.04M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 4.971M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | -1.206M |
Ampio Pharmaceuticals Inc | 0.00 |